In light of ARASENS presented at GU ASCO 2022, how do you approach treatment of de novo metastatic hormone sensitive prostate cancer?  

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Vanderbilt-Ingram Cancer Center
I agree with @Andrew J. Armstrong's thoughtful res...
Sign in or Register to read more